Mucinex is one of 119 small molecule programs targeting Sinusitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
152 competitors in Pneumonia
Mucinex
Prevacid
Plaquenil
Innohep
Jakafi
Primaquine
Acanya
Avlosulfon
Zantac 150
Virazole
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Dec 18, 2002
MUCINEX
NDA NDA021282
Sources
Details